zilucoplan

CHEBI:CHEBI_751815

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
route
SUBCUTANEOUS
active_ingredient_strength
1 g/g
marketing_start_date
20230110
package_marketing_start_date
10-JAN-23
nui
N0000175974
pharm_class_epc
Complement Inhibitor [EPC]
pharm_class
Complement Inhibitors [MoA]
pharm_class_moa
Complement Inhibitors [MoA]
labeler_name
PolyPeptide Laboratories France
manufacturer_name
UCB, Inc.
generic_name
ZILUCOPLAN
brand_name
ZILBRYSQ
brand_name_base
ZILBRYSQ
product_ndc
50474-991
application_number
NDA216834
spl_id
1ce84f37-361b-7529-e063-6294a90ac847
active_ingredient_name
ZILUCOPLAN
package_ndc
50474-991-80
package_description
4 CARTON in 1 BOX (50474-991-80) / 7 SYRINGE, GLASS in 1 CARTON / .574 mL in 1 SYRINGE, GLASS
rxcui
2672507
unii
YG391PK0CC
spl_set_id
9f1d53d6-e495-4a3a-8bb9-680a15d25034
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class